Myomo Inc (NYSEAMERICAN:MYO)’s stock price traded up 6.3% on Wednesday . The stock traded as high as $0.90 and last traded at $0.84, 274,918 shares were traded during mid-day trading. An increase of 234% from the average session volume of 82,338 shares. The stock had previously closed at $0.79.
Several equities analysts recently weighed in on the stock. Ascendiant Capital Markets assumed coverage on shares of Myomo in a research note on Tuesday. They issued a “buy” rating and a $2.00 target price for the company. Zacks Investment Research downgraded Myomo from a “buy” rating to a “hold” rating in a report on Tuesday, July 23rd.
Myomo (NYSEAMERICAN:MYO) last announced its quarterly earnings results on Monday, May 13th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.03. The business had revenue of $0.83 million for the quarter, compared to analyst estimates of $0.86 million.
About Myomo (NYSEAMERICAN:MYO)
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community.
Featured Story: The Structure of a Futures Contract
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.